Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5403277 | 0.94 | APOBEC3G (0.39) | APOBEC3GFFAR1PDCD1CD274TSHR | |
| Pyridine SCHEMBL1220102 | 0.87 | FFAR1 (0.37) | APOBEC3GFFAR1PDCD1CD274TSHR | |
| SCHEMBL5750300 | 0.81 | APOBEC3G (0.43) | APOBEC3GFFAR1PDCD1CD274TSHR | |
| SCHEMBL3037715 | 0.80 | APOBEC3G (0.34) | APOBEC3GFFAR1PDCD1CD274 | |
| SCHEMBL9862093 | 0.80 | HSPA5 (0.40) | CYP1A1CYP1A2CYP1B1PYCR1HSPA5 | |
| SCHEMBL15000783 | 0.79 | PTGDR2 (0.41) | APOBEC3GFFAR1PDCD1CD274PDK2 | |
| SCHEMBL13821279 | 0.79 | KDM4E (0.36) | FFAR1CYP1A2SLC6A4ALDH1A1 | |
| SCHEMBL4170188 | 0.78 | TRPA1 (0.36) | TSHRCYP1A1CYP1A2CYP1B1PYCR1 | |
| SCHEMBL1253891 | 0.76 | CYP1A1 (0.33) | CYP1A1CYP1A2CYP1B1PYCR1 | |
| SCHEMBL21410141 | 0.76 | APOBEC3G (0.43) | APOBEC3GFFAR1PDCD1CD274TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11263787-A | — | — | None | — | — | JP | disclosed |
| US-11814462-B2 | Functionalized cyclic polymers and methods of preparing same | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| CN-117000164-A | Method for preparing alkynol by applying micro-channel reactor to liquid ammonia/acetylene system | 日照盛泉新材料科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-117003760-A | Preparation method of quinoline condensed ring derivative | 广东工业大学 | 2023-11-07 | — | — | CN | disclosed |
| CN-114853556-B | New synthesis method of 5H-dibenzo [ a, d ] cycloheptene skeleton | 绍兴文理学院 | 2023-08-29 | — | — | CN | disclosed |
| EP-3625218-B1 | PROCESS FOR HYDROCYANATION OF TERMINAL ALKYNES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2023-03-01 | — | — | EP | disclosed |
| US-11584773-B2 | Phosphorous protecting groups and methods of preparation and use thereof | AGILENT TECHNOLOGIES, INC. (US) | 2023-02-21 | — | — | US | disclosed |
| CN-114907389-A | Boronic acid derivatives | 首药控股(北京)股份有限公司 | 2022-08-16 | — | — | CN | disclosed |
| CN-114853556-A | Novel synthesis method of 5H-dibenzo [ a, d ] cycloheptene skeleton | 绍兴文理学院 | 2022-08-05 | — | — | CN | disclosed |
| US-20220056167-A1 | Functionalized Cyclic Polymers and Methods of Preparing Same | NATIONAL SCIENCE FOUNDATION | 2022-02-24 | — | — | US | disclosed |
| CN-1665780-A | Tricyclic steroid hormone nuclear receptor modulators | LILLY CO ELI (US) | 2005-09-07 | — | — | CN | disclosed |
| EP-1519915-A2 | TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2005-04-06 | — | — | EP | disclosed |
| WO-2004052847-A2 | TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2004-06-24 | — | — | WO | disclosed |
| CN-1124260-C | Para retinoic acid | HOFFMANN LA ROCHE (CH) | 2003-10-15 | — | — | CN | disclosed |
| US-5986131-A | UNSATURATED CARBOXYLIC ACID DERIVATIVES AS LIGANDS AND RETINOIC ACID RECEPTORS | HOFFMANN-LA ROCHE INC. (US) | 1999-11-16 | — | — | US | disclosed |
| EP-0728742-B1 | Novel retinoids | HOFFMANN LA ROCHE (CH) | 1999-10-20 | — | — | EP | disclosed |
| JP-H11263787-A | PRODUCTION OF ISOCHROMANONE DERIVATIVE | JAPAN SCIENCE & TECHNOLOGY CORP | 1999-09-28 | — | — | JP | disclosed |
| CN-1136557-A | Para retinoic acid | HOFFMANN LA ROCHE (CH) | 1996-11-27 | — | — | CN | disclosed |
| EP-0728742-A2 | Novel retinoids | F. HOFFMANN-LA ROCHE AG (CH) | 1996-08-28 | — | — | EP | disclosed |
| EP-0061713-B1 | CYCLOPROPANECARBOXYLIC ACID ESTERS, THEIR PRODUCTION AND INSECTICIDAL AND ACARICIDAL COMPOSITIONS CONTAINING THEM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584773-B2 | Phosphorous protecting groups and methods of preparation and use thereof | POLN, POLRMT, NUDT21 | APOBEC3G 392/4885FFAR1 4683/4885PDCD1 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.